(December 12, 2016) Prof. Webster Santos
, along with Profs. Alban Gaultier and Kevin Lynch at UVA, received pilot funding to study drugs developed in the Santos lab as potential multiple sclerosis (MS) therapy. MS
is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. The 70K grant from the UVA-VTC neuroscience seed fund program is designed to bring neuroscience investigators together to tackle important questions and perform transformative work.